These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 11321388

  • 1. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.
    Bunn SK, Bisset WM, Main MJ, Golden BE.
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):171-7. PubMed ID: 11321388
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA, Leach ST, Day AS.
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Age-dependent variations in fecal calprotectin concentrations in children.
    Rugtveit J, Fagerhol MK.
    J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):323-4; author reply 324-5. PubMed ID: 11964964
    [No Abstract] [Full Text] [Related]

  • 6. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 7. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
    Gucenmez OA, Kume T, Makay B, Babayigit O, Arslan N, Unsal E.
    Int J Rheum Dis; 2018 Oct; 21(10):1844-1848. PubMed ID: 30345692
    [Abstract] [Full Text] [Related]

  • 8. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
    Fagerberg UL, Lööf L, Myrdal U, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
    [Abstract] [Full Text] [Related]

  • 9. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC, Bachmann Holmetoft U, Ingdam Halkjær S, Angeliki Krogfelt K, Munk Petersen A.
    Scand J Gastroenterol; 2016 Apr; 51(2):211-7. PubMed ID: 26359672
    [Abstract] [Full Text] [Related]

  • 10. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [Abstract] [Full Text] [Related]

  • 11. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J.
    Korean J Gastroenterol; 2016 May 25; 67(5):233-7. PubMed ID: 27206433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fecal calprotectin levels in children is more tightly associated with histological than with macroscopic endoscopy findings.
    Hradsky O, Ohem J, Mitrova K, Durilova M, Kotalova R, Nevoral J, Kolho KL, Bronsky J.
    Clin Lab; 2014 May 25; 60(12):1993-2000. PubMed ID: 25651733
    [Abstract] [Full Text] [Related]

  • 15. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    J Crohns Colitis; 2015 Jan 25; 9(1):50-5. PubMed ID: 25518048
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 25; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 19. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL, Raivio T, Lindahl H, Savilahti E.
    Scand J Gastroenterol; 2006 Jun 25; 41(6):720-5. PubMed ID: 16716972
    [Abstract] [Full Text] [Related]

  • 20. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S.
    Inflamm Bowel Dis; 2008 May 25; 14(5):669-73. PubMed ID: 18240279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.